ZLZong-Fang Li

Zong-Fang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zong-Fang Li has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Identification of Novel Low Molecular Weight Serum Peptidome Biomarkers for Non‐Small Cell Lung Cancer (NSCLC)

    by Juan Yang, Yong‐Chun Song, Tu‐Sheng Song, Xiao‐Yan Hu, You‐Min Guo, Zong‐Fang Li, Cheng‐Xue Dang, Chen Huang

    To identify discriminating protein patterns in serum samples among non-small cell lung cancer (NSCLC), chronic obstructive pulmonary disease (COPD), pneumonia, and healthy controls. To discover specific low molecular weight (LMW) serum peptidome biomarkers and establish a diagnostic pattern for NSCLCby using proteomic technology. We used magnetic bead-based separation followed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to identify patients with NSCLC, COPD, and pneumonia. A total of 154 serum samples were analyzed in this study, among which there were 60 serum samples from NSCLC patients, 30 from patients with other lung-related diseases (16 pneumonia patients and 14 patients with COPD) as disease controls, and 64 from healthy volunteers as healthy control. The mass spectra, analyzed using ClinProTools software, distinguished between cancer patients and healthy individuals based on GA algorithm model. In this study, we generated numerous discriminating m/z peaks as well as disease-specific discrimination peaks. A set of five potential biomarkers (m/z: 7,763.24, 1,012.61, 4,153.16, 1,450.55, and 2,878.89) could be used as the diagnostic biomarkers to distinguish NSCLCpatients from healthy controls. In the training set, patients with NSCLC could be identified with sensitivity of 97.5% and specificity of 98.8%. Similar results were obtained in the testing set, showing 80.7% sensitivity and 91.2% specificity. Our study demonstrated that a combined application of magnetic beads with MALDI-TOF MS technique was suitable for identification of serum biomarkers for NSCLC.


    • 1 February 2011
      • Vol. 31  (2) , 256-8

    [STAT1 and STAT2 participate in growth inhibition of human hepatoma HepG2 cells induced by phosphatidylethanolamine].

    by Li-Ying Liu, Chen Huang, Zong-Fang Li, Ai-Ying Wang, Xiao-Yan Hu, Lei Ni, Lin Yu, Tu-Sheng Song

    To investigate the roles of STAT1 and STAT2 in growth inhibition induced by phosphatidylethanolamine (PE) in human hepatoma HepG2 cells. The growth of HepG2 cells exposed to 0.125, 0.25, 0.5 and 1.0 mmol/L PE was assessed by MTT assay, and the expressions of STAT1 and STAT2 were analyzed using immunocytochemical assay. PE inhibited the growth of HepG2 cells in a dose-dependent manner and increased the expression of STAT1 and STAT2 in comparison with those in the control group. AG490, an inhibitor of JAKs, partially reversed PE-induced growth inhibition of HepG2 cells. STAT1 and STAT2 are involved in the growth inhibition of human hepatoma HepG2 cells induced by PE.


  • Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target

    by Li, Zhi-Dong Wang, Chen Huang, Zong-Fang Li, Jun Yang, Bao-Hua Li, Rong-Rui Liang, Zhi-Jun Dai, Zhong-Wei Liu

    Hepatocellular carcinoma (HCC) is an aggressive cancer with a dismal outcome largely due to metastasis and postsurgical recurrence. Thus, the inhibition of invasion and metastasis is of great importance in its therapies. Medicinal plants or ethnopharmacology used in folklore medicine continue to be an important source of discovery and development of novel or potential therapeutic agents for treatment of cancer. Chrysanthemum indicum, one of the medicinal plants or ethnopharmacology, is being used for treatment of many diseases including cancer. However, this plant molecular mechanisms underlining the anti-metastatic effects have not been well documented. In this study, Chrysanthemum indicum ethanolic extract (CIE) significantly suppressed proliferation and invasion of MHCC97H cells, one of the HCC cell lines with high metastatic potential, in a dose-dependent manner. CIE markedly decreased MMP-2 and MMP-9 expression, increased simultaneously TIMP-1, and TIMP-2 expression further restoring their balance in the cancer cells. The present study indicates that CIE reduced MHCC97H cell metastatic capability, in part at least, through decrease of the MMP expression, simultaneous increase of the TIMP expression, further restoring their balance as therapeutic target in HCC. It is suggested that Chrysanthemum indicum is a potential novel therapeutic medicinal plant for treatment of HCC or cancer invasion and metastasis.


    • 20 December 2009
      • Vol. 122  (24) , 3043-7

    Changes of splenic macrophage during the process of liver cancer induced by diethylnitrosamine in rats.

    by Shu Zhang, Zong-Fang Li, Dun Pan, Chen Huang, Rui Zhou, Zhong-Wei Liu

    It is generally accepted that spleen plays a complex role in the tumor immunity, which would change in the different periods of cancer. In this study, we investigated the changes in the function of splenic macrophage (Mphi) in different stages of liver cancer induced by diethylnitrosamine (DEN) in rats. The aim was to support the characteristics of "two-way" and "phase" of spleen in tumor immunity. The model of pulmonary metastasis of liver cancer was established in forty male SD rats by DEN. In the 8th, 13th and 16th week, 10 rats were randomly chosen and sacrificed, and divided into cirrhosis, liver cancer and pulmonary metastasis groups depending on the pathological result, respectively. The other 10 rats were taken as control group. The Mphi was isolated by anchoring cultivation. The changes in ultrastructure, phagocytosis, cytokine secretion, antigen processing and presenting, and viability of splenic Mphi were detected by transmission electron microscopy, Vybrant(TM) Phagocytosis Assay, DQ(TM) Ovalbumin, and rat TNF-alpha ELISpot kits. Under the electron microscope, the Mphi in the control group had some pseudopodium-like prominences, and mitochondria, ribosome, rough endoplasmic reticulum, lysosome can be found in the cytoplasm, and phagocytized RBC. In the liver cirrhosis and liver cancer group, Mphi had more prominences, meanwhile much more mitochondria, ribosome, rough endoplasmic reticulum, lysosome can be found in the cytoplasm, especially in the liver cancer group. In the pulmonary metastasis group, the Mphi was swelling, with few organelle. As compared to the control group, the function of splenic Mphi increased in cirrhosis and cancer groups, but decreased in metastasis group (phagocytosis rate: (84.7 +/- 1.9)%, (89.5 +/- 3.1)%, and (36.0 +/- 2.6)% vs (75.6 +/- 1.7)%, P < 0.05, P < 0.01; viability: (1.53 +/- 0.15)%, (1. +/- 0.14)%, and (1.12 +/- 0.29)% vs (1.48 +/- 0.17)%, P < 0.05, P < 0.01; TNF-alpha secretion: (741.0 +/- 52.9)%, (1126.2 +/- 174.5)%, and (313.8 +/- 50.8)% vs (626.6 +/- 24.6)%, P < 0.05, P < 0.01; positive cell rate of antigen processing and presenting: (24.03 +/- 1.87)%, (27.95 +/- 2.63)%, and (10.46 +/- 2.16)% vs (16.45 +/- 1.86)%, P < 0.01). In the stage of cirrhosis and early cancer, the immune functions of splenic Mphi were reinforced. It may promote the non-specificity tumor immunity. On opposite, in the stage of pulmonary metastasis, the immune functions of splenic Mphi were impaired. It may lead to the decrease of tumor immunity.


  • The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells

    by Yuan, Aihua Yuan, Zongfang Li, Xinqiu Li, Shanyong Yi, Shukui Wang, Yongdong Cai, Hongyong Cao

    Increasing data indicate that stress hormones and their corresponding receptors play an important role in the carcinogenesis and progression of hepatocellular carcinoma (HCC). However, there is presently no study investigating the influence of stress hormones in correlation with β2-AR on human HCC cells. We examined the expression of α1- and β-ARs in human HCC cell line HepG2 and MHCC97H cells in comparison with that in human normal hepatic cell line HL-7702 cells (L-02), and the influence of isoproterenol (ISO) on the growth of these HCC cells using blocking agents in correlation with β2-AR and its downstream signaling pathways. We found that α1-AR was down-regulated and β2-AR was up-regulated in HepG2 and MHCC97H cells. ISO dose-dependently promoted the growth of both HepG2 and MHCC97H cells. ISO-induced growth and survival of HCC cells were effectively attenuated by ICI 118551, U0126 and PD153035, but not by H-89 or LY294002. ISO transiently activated MAPK/ERK1/2 in tumor cells which could be blocked either by ICI 118551 or U0126, but not by H-89, LY294002, or PD153035. These findings indicate that ISO mimicking a mitogen promoted the growth of HepG2 and MHCC97H cells via β2-AR-mediated activation of both MAPK/ERK1/2 dependent and independent signaling pathways, and ISO activated MAPK/ERK1/2 by an EGFR-independent mechanism.


  • Open Access

    Psychological aspect of cancer: From stressor to cancer progression (Review)

    by Li, Aihua Yuan, Shukui Wang, Zongfang Li, Chen Huang

    Substantial evidence indicates that psychological stress can influence the incidence and progression of cancers, and adequate psychotherapies are beneficial to cancer patients. Recently, the mechanisms responsible for the effects of psychological stress on cancer cells have been extensively investigated at the systemic, biochemical and molecular levels. Accumulating data indicate that the effects of psychological stress on cancer cells are mainly mediated by key stress-related mediators and their corresponding receptors in multi-fold pathways: chronic stressors act on the paraventricular nucleus and the suprachiasmatic nuclei. The effects are then transmitted through the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis, amplified by the unchecked release of stress-related mediators and altered behaviors. These mediators act as immunosuppressors or mitogens in the tumor micro-environment. The converging effects of psychological stress on cancer cells finally signal through receptors of the stress mediators and cytokines to activate the intracellular pro-proliferative and pro-migratory signaling pathways, and reset the molecular clock in tumor cells. Understanding these action mechanisms of psychological stress in promoting the growth and invasion of cancer cells is crucial for devising effective interventions. Contents Introduction Chronic stressors act on the nervous system Systemic pathways and neuroendocrine transmitters Modulation of the tumor microenvironment Converging effects on cancer cells Questions and perspective Introduction There is a long-standing hypothesis that psychosocial factors can influence the incidence and progression of cancers, and adequate psychotherapies may be beneficial to cancer patients (1,2). Clinical and epidemiological studies have also documented a prevalence of psychological stress among cancer patients and the adverse effects on cancer outcomes. However, stress-related disorders in cancer patients are not adequately assessed nor treated due to the limited knowledge of the psychological aspect of cancer and the ineffectiveness of psychotherapies (3,4). Not until the recent past few years, by using in vitro animal models and human clinical perspective study approaches, have researchers begun to uncover the complex relationship between psychosocial stress and cancer progression at the systemic, biochemical and molecular levels. Accumulating data indicate that the psychological stress caused by chronic stressors is a major risk factor for cancer occurrence, growth and metastasis (5–8). Psychological stress refers to the emotional and physiological reactions experienced when an individual confronts a situation in which the adaptation demands go beyond their coping resources (9). The effects of psychological stress on cancer cells are mediated by the same key stress-related mediators and their corresponding receptors of stress response in multifold pathways (2,6–8). Understanding the action mechanisms of psychosocial stress in promoting cancer progression is crucial for devising effective interventions. In this article, we briefly review the recent theory of the mechanisms involved from stressor to cancer progression. Chronic stressors act on the nervous system Chronic stressors first act on the central nervous system, especially the paraventricular nucleus (PVN) and the suprachiasmatic nuclei (SCN), causing an automatic process which disrupts homeostasis (2,9–12). To maintain homeostasis, two strictly controlled information-processing cascades precede in similar ways to properly maintain the stress response and to keep the central pacemaker in position: the sympathetic nervous system (SNS)-adrenal medullary axis and the hypothalamic-pituitary-adrenal (HPA) axis. Activation of the SNS causes increased release of norepinephrine (NEPI) from sympathetic nerve terminals, and NEPI and epinephrine (EPI) from the adrenal medulla. Activation of the HPA axis causes increased release of corticotrophin-releasing hormone (CRH) from the PVN of the hypothalamus, resulting in increased secretion of adrenocorticopic hormone (ACTH) in the anterior pituitary. ACTH, in turn, stimulates secretion of glucocorticoid (GC) hormones from the adrenal cortex. GCs modulate the activity of the HPA axis via negative feedback effects on glucocorticoid receptors (GRs) in the hippocampus. However, the information-processing cascade is out of control, and stress-related mediators can not be supressed during psychological stress, resulting in constant abnormalities in hormone levels and behavior (2,9,10,13). Meanwhile, the central circadian rhythms are disrupted for the dysfunction of the central pacemaker located in the SCN (11,12). Circadian rhythms are 24-h oscillations in behavior and physiology, which provide organisms a survival advantage when confronted with cyclic changes in the environment. Circadian rhythms are driven by an internal timing machine – the ‘circadian clock’ operated by numerous gene products in the central pacemaker as well as in most peripheral tissues. Peripheral clocks exist in almost every cell type to regulate daily changes in cell biology. To guarantee normal growth and avoid tumor formation, the timing of cell division must be under strict control. The central pacemaker controls peripheral clocks mainly through the HPA axes and SNS. GCs and melatonin (N-acetyl-5-methoxytryptamine) are in feedback control of CRH release from SCN or HPA axes. The function of the circadian pacemaker is disrupted due to two major mechanisms: loss of feedback control of CRH and up-regulation of the operating genes of the circadian pacemaker such as gastrin-releasing peptide (GRP) and GRP receptors (GRPRs) in SCN (Fig. 1).Figure 1.A schematic representation of the mechanism involved from stress to cancer progression. Chronic stressors act on the paraventricular nucleus (PVN) and suprachiasmatic nuclei (SCN). The effects are then transmitted through the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis by checked release of stress-related mediators. Failure in suppressing the generation of stress-related mediators and disruption of the central circadian rhythms due to repeated stress response result in dysfunction of the endocrine, metabolic and immune systems, which consequently promote the progression of cancer. AVP, arginine vasopressin; ANS, autonomic nervous system (modified from refs. 2 and 11). Systemic pathways and neuroendocrine transmitters The question of how psychological stress affects cancer cells has intrigued both researchers and patients. Recent studies have confirmed that the effects of psychological stress on cancer cells are mediated by key stress hormones and their corresponding receptors through similar processes observed in the stress response (2,6–8,11–14). At least three systemic pathways are involved (Fig. 1): the SNS and the sympathetic-adrenal medullary axis, the HPA axis and an altered pattern of coping. First, the sympathetic fibers that descend from the brain into peripheral tissues can release a wide variety of neurotransmitters that influence cancer growth by binding to receptors on cancer cells. Some of the most significant neurotransmitters recently identified by a series of studies include cortisol, EPI, NEPI and GRP. Sympathetic signals increase the release of EPI, NEPI and GRP from the sympathetic terminal fibers or even tumor cells. Second, the sympathetic-adrenal-medullary axis and the hypothalamic-pituitary-adrenal/ovarian axis can increase the release of EPI, NEPI, cortisol, GRP, prolactin, growth hormone, melatonin, β-endorphin and enkephalin from the brain, pituitary and adrenal glands. The unchecked release of these stress-related neurotransmitters results in their chronic-flattened elevations in both blood and tissues. Finally, the altered pattern of coping may have an equal importance in linking stressors to cancer cells. The altered pattern of coping refers to the unhealthy behavior of individuals who suffer from psychological stress developed when coping with an adverse situation. Commonly observed unhealthy behaviors include overeating, alcoholism, sleeplessness, smoking, reduction in socialization and non-compliance to medical treatments. Through the three main pathways and numerous mediators, the effects of psychological stress are amplified and transmitted as humoral and behavioral functions to the blood, tissues and the coping mechanism. Modulation of the tumor microenvironment Changes in stress-related neuroendocrine transmitters during psychological stress lead to a modulation of the tumor microenvironment and immune cells. The first most important mechanism is the modulation of the immune function against tumor cells. Recent studies indicate that the impact of stress on the immune response is mediated by a bidirectional signal network between the nervous, endocrine and immune systems, and chronic stressors are associated with suppression of both cellular and humoral immune functions (Fig. 2) (12–16). For example, stress hormones affect the immune function through receptors present on immune cells, and the immune cells in tern modulate the activity of the hypothalamus by producing cytokines. GRs expressed on a variety of immune cells, which bind cortisol interfere with the function of nuclear factor-κB (NF-κB), which regulates the activity of cytokine-producing immune cells. Adrenergic receptors (ARs) bind EPI and NEPI to activate the cAMP response element-binding protein (CREB); CREB induces the transcription of genes encoding for a variety of cytokines. Changes in gene expression result in a shift of immune response from T-helper lymphocyte type 1 cells (Th1) to T-helper lymphocyte type 2 cells (Th2), which impairs the immune responses against tumor cells (12–16). The second important mechanism is the increased generation of mitogenic factors in the tumor microenvironment. Most of the stress-rela

    • 1 April 2009
      • Vol. 8  (2) , 201-8

    Emodin and baicalein inhibit pancreatic stromal derived factor-1 expression in rats with acute pancreatitis.

    by Zong-Fang Li, Xian-Ming Xia, Chen Huang, Shu Zhang, Jian Zhang, Ai-Jun Zhang

    Stromal derived factor-1 (SDF-1) is an efficacious leukocyte chemoattractant, which can attract lymphocytes and mononuclear cells from bloodstream into the site of inflammation. Emodin, an anthraquinone derivative from Radix et Rhizoma Rhei, and baicalein, a flavone from Scutellaria baicalensis Georgi, both have been reported to possess anti-inflammatory activities. The expression pattern of SDF-1 in experimental acute pancreatitis (AP) and the effect of emodin or baicalein on that are not well defined. The present study aimed to investigate the effects of emodin and baicalein on pancreatic myeloperoxidase (MPO) activity (reflecting leukocyte sequestration) and cytokine production, as well as tissue SDF-1 expression in the setting of AP. A rat model of AP was induced by administration of 5% sodium taurocholate through the biliopancreatic duct. The level of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and MPO in the pancreas, and serum amylase were tested by immunohistochemistry, ELISA and chromatometry. The expressions of SDF-1 alpha and SDF-1 beta were detected by real-time PCR, Western blotting, and immunohistochemistry. Combination of emodin and baicalein significantly reduced pancreatic TNF-alpha, IL-6 and MPO, and also inhibited pancreatic SDF-1 expression. The inhibition of SDF-1 expression by emodin and baicalein might contribute, in part at least, to the amelioration of pancreatic inflammation. The present study also shows benefits of simultaneous treatment of AP.


    • 1 December 2007
      • Vol. 27  (12) , 1841-4

    [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells].

    by Chen Huang, Jia-Yi Yao, Zong-Fang Li, Li-Ying Liu, Lei Ni, Tu-Sheng Song

    To study the mechanism of hepatic carcinoma cell apoptosis induced by small interfering RNA (siRNA)-mediated nuclear factor-kappaB (NF-kappaB) P65 silencing. Hepatic carcinoma SMMC-7721 cells were exposed to liposome-mediated transfection with NF-kappaB P65 siRNA synthesized by in vitro transcription, and the cells with empty liposome transfection and those without particular treatment served as the control groups. The expression of NF-kappaB P65 in the cells was detected by Western blotting, the cell viability examined by MTT assay, and the cell apoptosis assessed by flow cytometry. Immunohistochemistry was used to examine the expressions of Bcl-2 and Bax. siRNA transfection significantly inhibited the expression of NF-kappaB P65 in SMMC-7721cells, with inhibition rates of 64.74% compared with the untreated cells and of 34.52% compared with the liposome-treated cells. The siRNA-treated SMMC-7721 cells also exhibited significant decrease in cell proliferation by 33.39% and 27.23% in comparison with the untreated and liposome-treated cells, respectively. NF-kappaB P65 siRNA induced obvious cell apoptosis with down-regulated Bcl-2 and up-regulated Bax expressions. NF-kappaB p65 siRNA can induce SMMC-7721 cell apoptosis via the Bcl-2/Bax pathway.

  • HPV-16E6 can induce multiple site phosphorylation of p53

    by Huang, Ge Zhang, Lina Sun, Zongfang Li, Lusheng Si, Tusheng Song, Chen Huang, Wanggang Zhang

    Modulation of the activity of tumor suppressor p53 is a key event in the replication of many viruses. They could manipulate p53 function through modification of phosphorylation for their own purpose. However, there are scarce data on the relationship between high risk human papillomavirus (HPV) E6 protein and p53 phosphorylation status. Therefore, we used a mammalian green fluorescence protein (GFP) expression system to express HPV-16E6 with GFP fusion proteins in wild-type p53 cell lines, 293T, MCF-7, and SMMC-7721 to trace the traffic and subcellular location of E6 protein. By immunoblotting, we determined the positive phosphorylated sites of p53 in the context of HPV-16E6. Using immunofluorescence techniques, we observed the distribution of phosphorylated p53 in all the cells we used. In conclusion, HPV-16E6 was predominantly located in nuclei of wild-type p53 cells, and it was able to induce phosphorylation of p53 at multiple sites, such as Ser15, Ser20, and Ser392. The level and time of these phosphorylated sites of p53 were different in HPV-16E6 expressing cells. Furthermore, the phosphorylated p53 was localized in the nuclei together with HPV-16E6.